EcoDrugPlus

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002395
Gene Symbol: AGA03010
5 External references
121 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002437
Gene Symbol: AGA03010
5 External references
115 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP001595
Gene Symbol: AGA03010
5 External references
68 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP010216
Gene Symbol: AGA03010
4 External references
94 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP001805
Gene Symbol: AGA03010
4 External references
88 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002306
Gene Symbol: AGA03010
5 External references
114 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002468
Gene Symbol: AGA03010
5 External references
114 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP003768
Gene Symbol: AGA03010
5 External references
128 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP006612
Gene Symbol: AGA03010
5 External references
78 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP003816
Gene Symbol: AGA03010
5 External references
111 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP002754
Gene Symbol: AGA03010
4 External references
95 Possible Orthologues:

Kegg Id Aga03010 - Ribosome - Kegg Mapping Via Orthology Group K02890

Ensembl ID : AGAP006871
Gene Symbol: AGA03010
5 External references
125 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).